ArchPoint Investors’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,047,386
| Closed | -$8.01M | – | 56 |
|
|
2023
Q3 | $8.01M | Sell |
1,047,386
-67,240
| -6% | -$514K | 3.06% | 6 |
|
|
2023
Q2 | $8.33M | Hold |
1,114,626
| – | – | 3.22% | 7 |
|
|
2023
Q1 | $7.43M | Hold |
1,114,626
| – | – | 3.23% | 9 |
|
|
2022
Q4 | $8.59M | Sell |
1,114,626
-1,500
| -0.1% | -$11.6K | 4.07% | 6 |
|
|
2022
Q3 | $11.9M | Sell |
1,116,126
-151,304
| -12% | -$1.61M | 4.85% | 4 |
|
|
2022
Q2 | $10.3M | Hold |
1,267,430
| – | – | 4.09% | 5 |
|
|
2022
Q1 | $9.08M | Buy |
1,267,430
+12,000
| +1% | +$85.9K | 3.13% | 7 |
|
|
2021
Q4 | $21.5M | Buy |
+1,255,430
| New | +$21.5M | 6.38% | 3 |
|